Belviq Drug Interactions
Currently displaying 110 drugs known to have a moderate interaction with Belviq (lorcaserin).
Moderate interactions with Belviq (lorcaserin)
Note: Showing generic names only.
A
- acarbose
- acetohexamide
- albiglutide
- alogliptin
- alprostadil
- amphetamine
- apomorphine
- aripiprazole
- asenapine
- atomoxetine
- avanafil
B
C
- canagliflozin
- carvedilol
- cevimeline
- chlorpheniramine
- chlorpromazine
- chlorpropamide
- clozapine
- codeine
D
E
F
G
H
I
- iloperidone
- insulin
- insulin aspart
- insulin aspart protamine
- insulin degludec
- insulin detemir
- insulin glargine
- insulin glulisine
- insulin inhalation, rapid acting
- insulin isophane
- insulin lispro
- insulin lispro protamine
- insulin regular
- insulin zinc
- insulin zinc extended
L
M
- maprotiline
- mesoridazine
- metformin
- methdilazine
- methotrimeprazine
- metoclopramide
- metoprolol
- mexiletine
- midodrine
- miglitol
- mirabegron
- molindone
N
O
P
- paliperidone
- perphenazine
- pindolol
- pioglitazone
- pramlintide
- prochlorperazine
- promazine
- promethazine
- propafenone
- propiomazine
- propoxyphene
- propranolol
Q
R
S
T
- tadalafil
- tamsulosin
- tetrabenazine
- thiethylperazine
- thiothixene
- timolol
- timolol ophthalmic
- tirzepatide
- tolazamide
- tolbutamide
- tolterodine
- trifluoperazine
- triflupromazine
- trimeprazine
- troglitazone
V
Y
Z
Belviq alcohol/food interactions
There is 1 alcohol/food interaction with Belviq (lorcaserin).
Belviq disease interactions
There are 10 disease interactions with Belviq (lorcaserin) which include:
- valvulopathy
- bradycardia
- breast cancer
- depression
- hematological abnormalities
- liver disease
- priapism
- pulmonary hypertension
- renal dysfunction
- diabetics
More about Belviq (lorcaserin)
- Belviq consumer information
- Check interactions
- Compare alternatives
- Reviews (884)
- Drug images
- Latest FDA alerts (2)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: anorexiants
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.